Our Solution:
Table of content: What you will learn
Listen on the Go
Listen Time 5 mins
The Clinical Logic of OPTIMIZE — Why Every Protocol Starts Here
Every INFUSION SQ™ protocol begins with INFUSION SQ OPTIMIZE. Not because it is a preliminary step. Because it is the biological foundation without which the targeted axis interventions that follow cannot reach their full clinical potential.
OPTIMIZE delivers the metabolic and regenerative conditions the skin needs to respond. NAD+ and NMN restore mitochondrial energy production at the cellular level. PDRN activates the adenosine A2A receptor — stimulating fibroblast activity and tissue repair. ExoSignal™ BioDelivery Technology carries regenerative signaling molecules via biomimetic phospholipid nanovesicles to the target cellular compartment.
Before BRIGHT can modulate melanogenesis effectively, the microinflammatory environment needs to be modulated. Before DEFINE can drive collagen signaling, the fibroblast needs to be in a state of metabolic readiness. Before RENEW can reorganize the ECM, the cellular communication framework needs to be restored.
OPTIMIZE creates those conditions. Every time. For every axis. For every patient.
What OPTIMIZE Contains — and What Each Active Does
Cellular Energy Restoration
NAD+ (Nicotinamide Adenine Dinucleotide) is a metabolic cofactor essential for cellular energy production and DNA repair. NMN (Nicotinamide Mononucleotide) is the direct cellular precursor to NAD+ — supporting biosynthesis when direct NAD+ delivery faces cellular uptake challenges. Together, they address mitochondrial decline — one of the central mechanisms of skin aging — at the cellular level.
Regenerative Signaling
Salmon-derived PDRN activates adenosine A2A receptors with anti-inflammatory and pro-regenerative effects. ExoSignal™ BioDelivery Technology — a biomimetic phospholipid-based nanovesicle platform — delivers regenerative signaling molecules directly to the skin microenvironment, supporting biological communication and targeted cellular interaction.
Peptide and Structural Support
GHK-Cu (Copper Tripeptide-1) stimulates collagen and elastin synthesis and supports wound healing. Acetyl Hexapeptide-8 supports muscle-related skin relaxation and surface smoothness. The complete hyaluronic acid complex — native, cross-linked, hydrolyzed, and sodium forms — delivers multi-depth hydration across the dermal compartment.
Antioxidant and Barrier Defense
Glutathione, Ascorbyl Glucoside, and Niacinamide provide antioxidant protection, melanogenesis modulation, and barrier reinforcement — the three pillars of oxidative defense that support every skin quality axis simultaneously.
The Dual Role That Makes OPTIMIZE Clinically Unique
Most formulations serve one phase. OPTIMIZE serves two — and that is not a coincidence. It is a design decision.
In Phase 1 (Prepare), OPTIMIZE primes the biological environment — modulating microinflammation, restoring cellular communication, and activating the metabolic conditions required for targeted intervention.
In Phase 3 (Optimize), it sustains the results — maintaining fibroblastic activity, supporting regenerative signaling, and preserving the biological conditions established during the treatment phase. Every maintenance session, regardless of axis, includes OPTIMIZE.
The Practice Math — Why OPTIMIZE Is Your Most Consistent Monthly Reorder
The protocol structure of INFUSION SQ™ creates a predictable reorder pattern that reflects clinical logic — not a sales strategy.
Consider a practice with 10 patients on INFUSION SQ™ protocols across three axes:
- → 10 patients × 1 OPTIMIZE session at protocol start = 10 units immediately.
- → Every 15 days during Phase 2 = 2 sessions per patient per month of axis formulation.
- → Every 3 months during Phase 3 = 1 OPTIMIZE session per maintenance visit, per patient, indefinitely.
OPTIMIZE is the only formulation that appears in every phase of every protocol. It is the formulation that scales with your patient volume — not a one-time purchase, but the clinical touchpoint that returns every maintenance cycle.
A patient on any INFUSION SQ™ axis does not complete the protocol and leave. They return for maintenance — always with OPTIMIZE. That is retention built into the clinical design.
Skin of Color — Why OPTIMIZE Is Especially Relevant
Latin skin and skin of color present distinct melanocyte reactivity. Inflammatory control and barrier preservation are not optional in these protocols — they are the prerequisite for any corrective intervention to be safe and effective.
OPTIMIZE's emphasis on microinflammatory modulation, barrier reinforcement, and NAD+-driven cellular repair makes it particularly well-suited as the entry point for patients with reactive skin, fitzpatrick IV–VI, or a history of post-inflammatory hyperpigmentation following aesthetic treatments.
Starting every protocol with OPTIMIZE is not just clinically sound — it is clinically responsible for the skin types most likely to be affected by protocol errors.
The Long-Term View — Building a Practice Around Skin Quality
The practices that build long-term patient relationships are the ones that give patients a reason to return — not just a result to come back for.
INFUSION SQ™ does both. It delivers measurable, progressive skin quality improvement across four biological axes. And it creates a maintenance relationship — anchored by OPTIMIZE — that keeps patients engaged with their skin quality trajectory over months and years, not just weeks.
The patient who completes a BRIGHT protocol for tone uniformity and returns every three months for OPTIMIZE maintenance is not a loyal patient because of marketing. They are a loyal patient because their skin continues to improve — and they know why.
That is the clinical foundation of practice retention. And OPTIMIZE is its cornerstone.
Explore the INFUSION SQ™ Collection
Dr. Juan Camilo Calderón
Medical Doctor
All protocols validated by Juan Camilo Calderón, MD — XTETIC Medical Director. A physician trained in Dermatology and aesthetic medicine immunology. He is also a professor, scientific consultant, international speaker, and dermatology publication reviewer.